Study Start-up

SOLUTION FOR LIFE SCIENCES

Automate and organize the clinical study start-up process across the globe – powered by Low-code, BPM and Case Management.

The Study Start-up solution enables Life Sciences companies to leverage a Low-code, BPM and Case Management platform to automate and organize the Clinical Study Start-up process across the globe.

Request Solution Demo

Please tell us about yourself

I confirm I have read the privacy policy.*

Study Start-up made easy

SS-v1

One of the key challenges faced by any global Life Sciences company is keeping up with and adapting to the amount of change and variation in regulatory requirements around the world. The Study Start-up solution provides a way to automate the clinical study start-up process from end-to-end, providing rich user experience, flexible workflow and deep insight into the tasks orchestrated across the study sites globally.

For a Life Sciences company, when a new drug is ready to be included in a clinical trial, a fairly complicated regulatory process is followed to get the study sites ready. An off-the-shelf Study Start-up solution for site initiation often contains rigid processes that don’t accommodate variations in global regulatory requirements. 

The Study Start-up solution orchestrates the internal collaboration of the regulatory process for circulating the new drug to various sites where it can be administered within the trial according to the Local Regulatory Health Authority. The ability to automate these tasks while providing real-time transparency is a key requirement for a successful and timely site initiation. This solution:

  • Assigns tasks for new site initiation including IMP Greenlight and site visit date
  • Collects and submits mandatory documents for each site initiation based on local country requirements
  • Digitally signed approval of documents to release the drug to the new sites

Request Solution Demo

Please tell us about yourself

I confirm I have read the privacy policy.*

Key Highlights

Request a Demo

I confirm I have read the privacy policy.*

Scroll to Top